Sugammadex v.s. Neostigmine/Glycopyrrolate

Summary

The aim of study is to clarify the role of sugammadex in ENT surgery patients with a prior history of postoperative urinary retention, benign prostatic hypertrophy, or a history of prostate cancer, to prevent postoperative urinary retention. The main question it aims to answer are: * Anticholinergic agent interferes the postoperative urination * Sugammadex does not interfere postoperative urination Sugammadex can be recommended for these patients with high risk in postoperative urinary retention in the future.

Timeline

Start

2024-05-01

Primary completion

2025-06-12

Completion

2025-08-12

Drugs

Indications